Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts

The discovery of immune checkpoint inhibitors (ICIs) has now been universally acknowledged as a significant breakthrough in tumor therapy after the targeted treatment of checkpoint molecules: anti-programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) and anti-cytotoxic T lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuchen, Zhang, Hao, Liu, Chao, Wang, Zeyu, Wu, Wantao, Zhang, Nan, Zhang, Longbo, Hu, Jason, Luo, Peng, Zhang, Jian, Liu, Zaoqu, Peng, Yun, Liu, Zhixiong, Tang, Lanhua, Cheng, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386972/
https://www.ncbi.nlm.nih.gov/pubmed/35978433
http://dx.doi.org/10.1186/s13045-022-01325-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386972/
https://www.ncbi.nlm.nih.gov/pubmed/35978433
http://dx.doi.org/10.1186/s13045-022-01325-0

Ejemplares similares